Maider Medical Industry Equipment Co. Ltd. (SHA:688310)
China · Delayed Price · Currency is CNY 17.08
+0.37 (2.21%)
At close: Mar 6, 2026
SHA:688310 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 447.42 | 271.28 | 476.26 | 380.08 | 313.06 |
Other Revenue | - | 3.58 | 3.96 | 3.41 | 2.46 |
| 447.42 | 274.85 | 480.22 | 383.49 | 315.53 | |
Revenue Growth (YoY) | 62.79% | -42.77% | 25.22% | 21.54% | 19.89% |
Cost of Revenue | - | 156.93 | 235.72 | 191.43 | 159.32 |
Gross Profit | 447.42 | 117.92 | 244.5 | 192.06 | 156.21 |
Selling, General & Admin | - | 120.26 | 118.01 | 93.77 | 64.56 |
Research & Development | - | 40.41 | 33.18 | 36.66 | 38.46 |
Other Operating Expenses | 387.72 | -9.6 | -16.01 | -9.02 | -5.89 |
Operating Expenses | 387.72 | 147.4 | 138.76 | 125.65 | 99.2 |
Operating Income | 59.7 | -29.48 | 105.74 | 66.41 | 57.01 |
Interest Expense | - | -0.06 | -0.08 | -0.1 | -0.12 |
Interest & Investment Income | - | 3.09 | 7.26 | 13.61 | 7.33 |
Currency Exchange Gain (Loss) | - | -0.33 | 0.53 | 0.68 | -0.71 |
Other Non Operating Income (Expenses) | 1.52 | -0.12 | -0.08 | -0.06 | -0.07 |
EBT Excluding Unusual Items | 61.22 | -26.9 | 113.37 | 80.54 | 63.45 |
Impairment of Goodwill | - | -10.42 | - | - | - |
Gain (Loss) on Sale of Investments | - | 2.24 | 2.66 | 0.15 | 0.03 |
Gain (Loss) on Sale of Assets | - | 0.3 | -0.03 | 0.21 | -0.06 |
Other Unusual Items | - | 5.55 | 11.43 | 6.33 | 7.05 |
Pretax Income | 61.22 | -29.23 | 127.43 | 87.22 | 70.47 |
Income Tax Expense | -4.04 | 0.78 | 17.82 | 10.2 | 6.5 |
Earnings From Continuing Operations | 65.26 | -30.01 | 109.61 | 77.02 | 63.97 |
Minority Interest in Earnings | - | 10.03 | -9.78 | -10 | 0.51 |
Net Income | 65.26 | -19.98 | 99.83 | 67.02 | 64.48 |
Net Income to Common | 65.26 | -19.98 | 99.83 | 67.02 | 64.48 |
Net Income Growth | - | - | 48.94% | 3.95% | 9.15% |
Shares Outstanding (Basic) | 163 | 167 | 164 | 165 | 164 |
Shares Outstanding (Diluted) | 163 | 167 | 164 | 165 | 164 |
Shares Change (YoY) | -2.02% | 1.75% | -0.60% | 0.32% | 0.63% |
EPS (Basic) | 0.40 | -0.12 | 0.61 | 0.41 | 0.39 |
EPS (Diluted) | 0.40 | -0.12 | 0.61 | 0.41 | 0.39 |
EPS Growth | - | - | 49.84% | 3.61% | 8.48% |
Free Cash Flow | - | -29.46 | 38.7 | -38.36 | -27.77 |
Free Cash Flow Per Share | - | -0.18 | 0.24 | -0.23 | -0.17 |
Dividend Per Share | - | - | 0.357 | 0.245 | 0.194 |
Dividend Growth | - | - | 45.81% | 26.30% | -23.99% |
Gross Margin | 100.00% | 42.90% | 50.91% | 50.08% | 49.51% |
Operating Margin | 13.34% | -10.73% | 22.02% | 17.32% | 18.07% |
Profit Margin | 14.59% | -7.27% | 20.79% | 17.48% | 20.43% |
Free Cash Flow Margin | - | -10.72% | 8.06% | -10.00% | -8.80% |
EBITDA | 90.5 | 1.32 | 134.17 | 81.44 | 63.48 |
EBITDA Margin | 20.23% | 0.48% | 27.94% | 21.24% | 20.12% |
D&A For EBITDA | 30.8 | 30.8 | 28.43 | 15.03 | 6.47 |
EBIT | 59.7 | -29.48 | 105.74 | 66.41 | 57.01 |
EBIT Margin | 13.34% | -10.73% | 22.02% | 17.32% | 18.07% |
Effective Tax Rate | - | - | 13.99% | 11.69% | 9.23% |
Revenue as Reported | - | 274.85 | 480.22 | 383.49 | 315.53 |
Advertising Expenses | - | 3.87 | 5.34 | 0.91 | 0.9 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.